+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Opioids Market by Opioid Types (Natural Opiates, Semi-Synthetic Opioids, Synthetic Opioids), Mode of Administration (Oral Administration, Parenteral Administration, Transdermal Administration), Application, End-User - Global Forecast 2025-2030- Product Image
Opioids Market by Opioid Types (Natural Opiates, Semi-Synthetic Opioids, Synthetic Opioids), Mode of Administration (Oral Administration, Parenteral Administration, Transdermal Administration), Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Opioids Market by Opioid Types (Natural Opiates, Semi-Synthetic Opioids, Synthetic Opioids), Mode of Administration (Oral Administration, Parenteral Administration, Transdermal Administration), Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977695
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Opioids Market grew from USD 10.88 billion in 2024 to USD 11.44 billion in 2025. It is expected to continue growing at a CAGR of 5.24%, reaching USD 14.79 billion by 2030.

The opioids market has long been a subject of intense scrutiny and debate across medical, regulatory, and commercial sectors. In recent years, rapid shifts in medical practices, evolving regulatory frameworks, and a renewed focus on patient safety have brought the market into sharper focus. This introductory section provides an overview of the current market dynamics, historical context, and the emerging trends that are shaping the future of this complex industry.

The evolution of opioid utilization has been driven by several key factors including advances in pharmaceutical research and development, changing consumer demands, and a global re-examination of pain management strategies. Market stakeholders have witnessed both remarkable innovations and challenging setbacks that underscore the dynamic nature of this landscape. Amid concerns over opioid dependency and illicit use, stakeholders are compelled to review historical data, assess current trends, and project future requirements more critically than ever before.

A renewed interest in balancing effective pain management with risk mitigation has provided a fertile ground for innovative products and tailored therapies. The sector now embraces a more holistic approach where regulatory oversight and medical needs are carefully harmonized. This report sets the stage by illuminating the intricate interplay between scientific advancements, regulatory changes, and evolving market strategies, offering a clear and focused lens into an industry in transition.

Transformative Shifts in the Landscape: Navigating Regulatory and Technological Evolution

Recent years have witnessed revolutionary transformations within the opioids market that have challenged long-held assumptions and traditional methodologies. The continuous evolution of medical technologies, increasingly sophisticated data collection methods, and the integration of real-world evidence have collectively reshaped the regulatory and commercial environment.

Innovative delivery systems, digital tracking, and enhanced patient monitoring have revolutionized the approach to opioid administration and distribution. As regulatory bodies impose stricter controls and demand higher levels of transparency and efficacy, manufacturers and distributors are forced to adapt quickly to maintain compliance and market share. In parallel, advancements in formulation, packaging, and administration methods have not only improved safety profiles but also expanded the market’s potential applications.

New treatment paradigms emphasize patient-centric care and holistic disease management. With interdisciplinary teams working alongside regulatory experts and clinical researchers, the industry is now better positioned to address both acute and chronic conditions with tailored interventions. The implementation of rigorous clinical trial protocols and post-marketing surveillance is driving a culture of accountability and continuous improvement. This transformative period is marked by proactive measures, a commitment to reducing misuse, and an altogether more rigorous system to assess benefits versus risks, ensuring that shifts in medical practice align with overarching public health goals.

Key Segmentation Insights: Leveraging Detailed Market Classifications for Strategic Advantage

A deep dive into the segmentation of the opioids market reveals a multifaceted landscape that caters to a variety of therapeutic needs and delivery methods. The analysis is partitioned by opioid types, further classifying the market into natural opiates, semi-synthetic opioids, and synthetic opioids. Within this structure, natural opiates are dissected into components such as codeine and morphine, whereas semi-synthetic opioids are broken down into products like hydrocodone and oxycodone. A further segmentation of synthetic opioids highlights compounds like fentanyl and methadone.

The segmentation extends beyond the categorization of opioid types to an assessment based on the mode of administration. This lens divides the market into oral, parenteral, and transdermal methods. An examination reveals that oral administration predominantly involves capsules and tablets, while parenteral methods are seen in the context of intramuscular and intravenous formulations. Transdermal systems have carved out their own niche by delivering controlled doses and offering alternative pathways for patient care.

Another critical segmentation is based on application areas. This perspective refines market understanding by focusing on usage in anesthesia, cough suppression, and pain management. Anesthesia is further deconstructed into general and regional types, offering insights into procedural and situational applications. Pain management itself is categorized under acute and chronic pain, providing clarity on the diverse therapeutic requirements and patient profiles the market strives to address.

Finally, the segmentation based on the end-user paints a detailed picture of the market’s ecosystem. Healthcare facilities, which include both clinics and hospitals, are recognized alongside home healthcare and specialized research institutes. The granular nature of these classifications allows stakeholders to pinpoint opportunities, align product offerings with precise needs, and tailor strategies to specific audience segments, thereby driving targeted marketing and operational efficiencies.

Based on Opioid Types, market is studied across Natural Opiates, Semi-Synthetic Opioids, and Synthetic Opioids. The Natural Opiates is further studied across Codeine and Morphine. The Semi-Synthetic Opioids is further studied across Hydrocodone and Oxycodone. The Synthetic Opioids is further studied across Fentanyl and Methadone.

Based on Mode of Administration, market is studied across Oral Administration, Parenteral Administration, and Transdermal Administration. The Oral Administration is further studied across Capsules and Tablets. The Parenteral Administration is further studied across Intramuscular and Intravenous.

Based on Application, market is studied across Anesthesia, Cough Suppression, and Pain Management. The Anesthesia is further studied across General Anesthesia and Regional Anesthesia. The Pain Management is further studied across Acute Pain and Chronic Pain.

Based on End-User, market is studied across Healthcare Facilities, Home Healthcare, and Research Institutes. The Healthcare Facilities is further studied across Clinics and Hospitals.

Key Regional Insights: Evaluating Global Opportunities and Regional Nuances

A comprehensive analysis of the regional markets sheds light on dynamic trends and growth opportunities embedded within specific geographic territories. The Americas continue to be a pivotal region characterized by a robust healthcare infrastructure and a strong drive for innovation. Regulatory frameworks in this part of the world are rapidly adapting to ensure access to essential medications while safeguarding against misuse, thereby framing an environment that is proactive and forward-thinking.

Europe, Middle East & Africa present a diverse mix of opportunities where variations in health policies, economic conditions, and cultural attitudes towards opioid usage offer a complex yet rewarding landscape. In Europe, the focus lies on balancing innovation with stringent safety standards, while the Middle East and Africa are witnessing gradual shifts towards modernization and enhanced healthcare delivery systems. Market players who are adept at navigating these nuanced regional policies are best positioned to capture emerging trends as regional regulatory protocols evolve.

In the Asia-Pacific region, rapid economic growth and increasing public health investments are fueling market expansion. This area is distinct for its accelerating pace of technological adoption and an ever-evolving regulatory environment. Combined with a wide demographic base and increasing incidence of chronic conditions, the Asia-Pacific market is emerging as a crucial arena for strategic investments and groundbreaking innovations. This regional snapshot reveals that despite inherent differences, all regions are aligned in their pursuit of improved patient outcomes and the establishment of robust, adaptive regulatory practices.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights: Spotlight on Industry Leaders and Their Strategic Prowess

The competitive landscape within the opioids market is defined by a cohort of influential companies that have a longstanding tradition of innovation and strategic foresight. Established industry leaders such as Abbott Laboratories, AbbVie Inc., Accord Healthcare, Ltd., and Alkermes plc have consistently demonstrated their ability to pioneer groundbreaking therapies and adopt adaptive business strategies. These companies are driving a culture of excellence by channeling investments into research and development and by embracing strategic partnerships that foster market resiliency.

In addition to these innovators, significant contributions have come from inimitable names like AmerisourceBergen Corporation and Bristol Laboratories Limited. These organizations have successfully navigated complex market dynamics through robust distribution networks and unwavering compliance with evolving regulatory mandates. Johnson Matthey Plc and Mallinckrodt LLC are also recognized for their sophisticated approach to product development, where emphasis is placed on leveraging new technologies to enhance drug formulations and delivery mechanisms.

Smaller entities, including Noramco, Inc. and Omnica Laboratories, complement the industry by filling crucial niches and targeting specialized segments of the market. Meanwhile, Purdue Pharma L.P. has continued to be a central figure, adapting its strategic initiatives to address evolving market challenges. Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc. further enrich the competitive landscape with robust portfolios that span across the opioid spectrum. Collectively, these companies have positioned themselves to not only meet current market demands but also to drive forward innovation in safety, efficacy, and patient-centric care options.

The report delves into recent significant developments in the Opioids Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Accord Healthcare, Ltd., Alkermes plc, AmerisourceBergen Corporation, Bristol Laboratories Limited, Johnson Matthey Plc, Mallinckrodt LLC, Noramco, Inc., Omnica Laboratories, Purdue Pharma L.P., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc..

Actionable Recommendations for Industry Leaders: Strategic Initiatives to Stay Ahead in a Transforming Market

To thrive in an environment characterized by rapid technological and regulatory transformations, industry leaders should consider several strategic initiatives. First, investing in robust research and development activities is paramount to drive innovations in drug formulations and delivery mechanisms. Such investments will allow organizations to address unmet clinical needs and create products that enhance patient safety and therapeutic outcomes. The emphasis should be on creating therapies that not only comply with stringent regulatory standards but also address new market segments driven by specific patient demographics.

Given the evolving market dynamics, organizations are encouraged to adopt flexible, adaptive strategies by leveraging real-world evidence and data analytics. The insights derived from granular market segmentation and regional trends should inform product development, marketing, and distribution strategies. Furthermore, building strategic alliances with healthcare providers, technology innovators, and regulatory experts can create a synergistic ecosystem that fosters continual improvement.

Ultimately, maintaining transparency and fostering collaboration across stakeholders - including policy makers, research institutes, and distributors - will be essential in ensuring long-term success in the opioids market. This proactive stance will allow companies to stay ahead of regulatory changes, capitalize on emerging opportunities, and ultimately deliver value in a rapidly shifting environment.

Synthesizing Insights to Chart a Future of Resilient Innovation

Exploring the multifaceted dimensions of the opioids market reveals a landscape marked by dynamic transformation, emergent segmentation insights, and robust regional opportunities. The detailed analysis confirms that strategic adaptation and innovation are central to navigating the complexities of these changing market dynamics. The comprehensive breakdown of opioid types, modes of administration, applications, and end-user segments provides a clear roadmap for stakeholders to align their strategic initiatives with current market trends.

Regional evaluations underscore the diversity of market environments, while insights into key industry players reinforce the importance of established yet agile business models. This strategic synthesis serves as a reliable compass for industry decision-makers, encouraging data-driven investments and focused risk management strategies. Overall, the analysis offers a balanced perspective that integrates regulatory imperatives, technological advances, and market-specific challenges into an actionable plan for sustainable growth and innovation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of chronic and acute pain conditions drives up opioid medication consumption
5.1.1.2. Expansion of healthcare infrastructure and services enhancing accessibility to opioid treatments
5.1.1.3. Expanding pharmaceutical research and development contributes to the introduction of new opioids
5.1.2. Restraints
5.1.2.1. High costs associated with opioid prescription management
5.1.3. Opportunities
5.1.3.1. Expanding telehealth services for opioid addiction counseling and treatment in underserved areas
5.1.3.2. Developing mobile apps for opioid addiction recovery support and community connectivity
5.1.4. Challenges
5.1.4.1. Stringent regulations to control the prescription and distribution of opioids
5.2. Market Segmentation Analysis
5.2.1. Opioid Types: Rising adoption of natural opiates due to their effective pain-relieving properties
5.2.2. Application: Rising application of opioids in pain management to manage both acute and chronic pain conditions
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Opioids Market, by Opioid Types
6.1. Introduction
6.2. Natural Opiates
6.2.1. Codeine
6.2.2. Morphine
6.3. Semi-Synthetic Opioids
6.3.1. Hydrocodone
6.3.2. Oxycodone
6.4. Synthetic Opioids
6.4.1. Fentanyl
6.4.2. Methadone
7. Opioids Market, by Mode of Administration
7.1. Introduction
7.2. Oral Administration
7.2.1. Capsules
7.2.2. Tablets
7.3. Parenteral Administration
7.3.1. Intramuscular
7.3.2. Intravenous
7.4. Transdermal Administration
8. Opioids Market, by Application
8.1. Introduction
8.2. Anesthesia
8.2.1. General Anesthesia
8.2.2. Regional Anesthesia
8.3. Cough Suppression
8.4. Pain Management
8.4.1. Acute Pain
8.4.2. Chronic Pain
9. Opioids Market, by End-User
9.1. Introduction
9.2. Healthcare Facilities
9.2.1. Clinics
9.2.2. Hospitals
9.3. Home Healthcare
9.4. Research Institutes
10. Americas Opioids Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Opioids Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Opioids Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2024
13.2. FPNV Positioning Matrix, 2024
13.3. Competitive Scenario Analysis
13.3.1. ANANDA Scientific announces a clinical trial evaluating Nantheia ATL5, in the treatment of co-occurring Opioid Use
13.3.2. FDA approval of over-the-counter naloxone nasal spray by Amneal set to transform opioid overdose intervention accessibility
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. OPIOIDS MARKET MULTI-CURRENCY
FIGURE 2. OPIOIDS MARKET MULTI-LANGUAGE
FIGURE 3. OPIOIDS MARKET RESEARCH PROCESS
FIGURE 4. OPIOIDS MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL OPIOIDS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL OPIOIDS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2024 VS 2030 (%)
FIGURE 9. GLOBAL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 11. GLOBAL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL OPIOIDS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 13. GLOBAL OPIOIDS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL OPIOIDS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 15. GLOBAL OPIOIDS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 17. AMERICAS OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES OPIOIDS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 19. UNITED STATES OPIOIDS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. OPIOIDS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 25. OPIOIDS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. OPIOIDS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OPIOIDS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL OPIOIDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. OPIOIDS MARKET DYNAMICS
TABLE 7. GLOBAL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL OPIOIDS MARKET SIZE, BY CODEINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL OPIOIDS MARKET SIZE, BY MORPHINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL OPIOIDS MARKET SIZE, BY HYDROCODONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL OPIOIDS MARKET SIZE, BY OXYCODONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL OPIOIDS MARKET SIZE, BY FENTANYL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL OPIOIDS MARKET SIZE, BY METHADONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL OPIOIDS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL OPIOIDS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL OPIOIDS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL OPIOIDS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL OPIOIDS MARKET SIZE, BY TRANSDERMAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL OPIOIDS MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL OPIOIDS MARKET SIZE, BY GENERAL ANESTHESIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL OPIOIDS MARKET SIZE, BY REGIONAL ANESTHESIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL OPIOIDS MARKET SIZE, BY COUGH SUPPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL OPIOIDS MARKET SIZE, BY ACUTE PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL OPIOIDS MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL OPIOIDS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL OPIOIDS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL OPIOIDS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL OPIOIDS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 84. CANADA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 85. CANADA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 86. CANADA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 87. CANADA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 88. CANADA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 89. CANADA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 90. CANADA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 91. CANADA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. CANADA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 93. CANADA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 94. CANADA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. CANADA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 96. MEXICO OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 97. MEXICO OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 98. MEXICO OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 99. MEXICO OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 100. MEXICO OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 101. MEXICO OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 102. MEXICO OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 103. MEXICO OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. MEXICO OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 105. MEXICO OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 106. MEXICO OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. MEXICO OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES OPIOIDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 122. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 130. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 134. AUSTRALIA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 135. AUSTRALIA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 136. AUSTRALIA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 137. AUSTRALIA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 138. AUSTRALIA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. AUSTRALIA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 140. AUSTRALIA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. AUSTRALIA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. AUSTRALIA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 143. AUSTRALIA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 144. AUSTRALIA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. AUSTRALIA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 146. CHINA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 147. CHINA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 148. CHINA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 149. CHINA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 150. CHINA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. CHINA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 152. CHINA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 153. CHINA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. CHINA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 155. CHINA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 156. CHINA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. CHINA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 158. INDIA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 159. INDIA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 160. INDIA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 161. INDIA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 162. INDIA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 163. INDIA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 164. INDIA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 165. INDIA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. INDIA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 167. INDIA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 168. INDIA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. INDIA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 170. INDONESIA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 171. INDONESIA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 172. INDONESIA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 173. INDONESIA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 174. INDONESIA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 175. INDONESIA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 176. INDONESIA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. INDONESIA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. INDONESIA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 179. INDONESIA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 180. INDONESIA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. INDONESIA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 182. JAPAN OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 183. JAPAN OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 184. JAPAN OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 185. JAPAN OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 186. JAPAN OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 187. JAPAN OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 188. JAPAN OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 189. JAPAN OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. JAPAN OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 191. JAPAN OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 192. JAPAN OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. JAPAN OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 194. MALAYSIA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 195. MALAYSIA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 196. MALAYSIA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 197. MALAYSIA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 198. MALAYSIA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 199. MALAYSIA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 200. MALAYSIA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 201. MALAYSIA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. MALAYSIA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 203. MALAYSIA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 204. MALAYSIA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. MALAYSIA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 206. PHILIPPINES OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 207. PHILIPPINES OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 208. PHILIPPINES OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 209. PHILIPPINES OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 210. PHILIPPINES OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. PHILIPPINES OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 215. PHILIPPINES OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 216. PHILIPPINES OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. PHILIPPINES OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 218. SINGAPORE OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 219. SINGAPORE OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 223. SINGAPORE OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. SINGAPORE OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 225. SINGAPORE OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. SINGAPORE OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 227. SINGAPORE OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 228. SINGAPORE OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. SINGAPORE OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 230. SOUTH KOREA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 231. SOUTH KOREA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 232. SOUTH KOREA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 233. SOUTH KOREA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 235. SOUTH KOREA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 236. SOUTH KOREA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 237. SOUTH KOREA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. SOUTH KOREA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 239. SOUTH KOREA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 240. SOUTH KOREA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 241. SOUTH KOREA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 242. TAIWAN OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 243. TAIWAN OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 244. TAIWAN OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 245. TAIWAN OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 246. TAIWAN OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 247. TAIWAN OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 248. TAIWAN OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 249. TAIWAN OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. TAIWAN OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 251. TAIWAN OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 252. TAIWAN OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 253. TAIWAN OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 254. THAILAND OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 255. THAILAND OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 256. THAILAND OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 257. THAILAND OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 258. THAILAND OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 259. THAILAND OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 260. THAILAND OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 261. THAILAND OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. THAILAND OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 263. THAILAND OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 264. THAILAND OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 265. THAILAND OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 266. VIETNAM OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 267. VIETNAM OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 268. VIETNAM OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 269. VIETNAM OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 271. VIETNAM OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 272. VIETNAM OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 273. VIETNAM OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. VIETNAM OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 275. VIETNAM OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 276. VIETNAM OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 277. VIETNAM OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 291. DENMARK OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 292. DENMARK OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 293. DENMARK OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 294. DENMARK OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 295. DENMARK OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 296. DENMARK OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 297. DENMARK OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 298. DENMARK OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. DENMARK OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 300. DENMARK OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 301. DENMARK OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 302. DENMARK OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 303. EGYPT OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 304. EGYPT OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 305. EGYPT OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 306. EGYPT OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 307. EGYPT OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 308. EGYPT OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 309. EGYPT OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 310. EGYPT OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 311. EGYPT OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 312. EGYPT OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 313. EGYPT OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 314. EGYPT OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 315. FINLAND OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 316. FINLAND OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 317. FINLAND OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 318. FINLAND OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 319. FINLAND OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 320. FINLAND OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 321. FINLAND OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 322. FINLAND OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 323. FINLAND OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 324. FINLAND OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 325. FINLAND OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 326. FINLAND OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 327. FRANCE OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 328. FRANCE OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 329. FRANCE OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 330. FRANCE OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 331. FRANCE OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 332. FRANCE OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 333. FRANCE OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 334. FRANCE OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 335. FRANCE OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 336. FRANCE OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 337. FRANCE OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 338. FRANCE OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 339. GERMANY OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 340. GERMANY OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 341. GERMANY OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 342. GERMANY OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 343. GERMANY OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 344. GERMANY OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 345. GERMANY OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 346. GERMANY OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 347. GERMANY OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 348. GERMANY OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 349. GERMANY OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 350. GERMANY OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 351. ISRAEL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 352. ISRAEL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 353. ISRAEL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 354. ISRAEL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 355. ISRAEL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 356. ISRAEL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 357. ISRAEL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 358. ISRAEL OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 359. ISRAEL OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 360. ISRAEL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 361. ISRAEL OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 362. ISRAEL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 363. ITALY OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 364. ITALY OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 365. ITALY OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 366. ITALY OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 367. ITALY OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 368. ITALY OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 369. ITALY OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 370. ITALY OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 371. ITALY OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2030 (USD MILLION)
TABLE 372. ITALY OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 373. ITALY OPIOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 374. ITALY OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2030 (USD MILLION)
TABLE 375. NETHERLANDS OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2030 (USD MILLION)
TABLE 376. NETHERLANDS OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2030 (USD MILLION)
TABLE 377. NETHERLANDS OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 378. NETHERLANDS OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2030 (USD MILLION)
TABLE 379. NETHERLANDS OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 380. NETHERLANDS O

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • Accord Healthcare, Ltd.
  • Alkermes plc
  • AmerisourceBergen Corporation
  • Bristol Laboratories Limited
  • Johnson Matthey Plc
  • Mallinckrodt LLC
  • Noramco, Inc.
  • Omnica Laboratories
  • Purdue Pharma L.P.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedMarch 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 11.44 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.79 Billion
Compound Annual Growth Rate5.2%
Regions CoveredGlobal
No. of Companies Mentioned14

Related Topics

Related Reports

Opioid Induced Constipation Market by Active Ingredients, Drug Class, Mode of Administration, Distribution Channel - Global Forecast 2025-2030 - Product Image

Opioid Induced Constipation Market by Active Ingredients, Drug Class, Mode of Administration, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Non-opioid Pain Patches Market Size, Share & Trends Analysis Report By Patch Type (Lidocaine, Diclofenac, Methyl Salicylate, Capsaicin, Ketoprofen), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Non-opioid Pain Patches Market Size, Share & Trends Analysis Report By Patch Type (Lidocaine, Diclofenac, Methyl Salicylate, Capsaicin, Ketoprofen), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Non-opioid Pain Patches Market by Patch Type, Indication, Distribution - Global Forecast 2025-2030 - Product Image

Non-opioid Pain Patches Market by Patch Type, Indication, Distribution - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Opioid Use Disorder Market Size, Share & Trends Analysis Report By Drug, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Opioid Use Disorder Market Size, Share & Trends Analysis Report By Drug, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Opioids Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Application, Route Of Administration, Distribution Channel, and Geography - Product Image

Opioids Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Application, Route Of Administration, Distribution Channel, and Geography

  • Report
  • 209 Pages
  • Global
From

About the Opioids Market

Analgesics are a class of drugs used to relieve pain. Opioids are a type of analgesic that act on the nervous system to reduce the intensity of pain signals sent to the brain. Opioids are typically prescribed for moderate to severe pain, and are often used to treat chronic pain. They can be taken orally, injected, or applied topically. Opioids can be highly addictive and have a high potential for abuse, so they are typically prescribed with caution. Opioids are a major component of the analgesic market, and are used to treat a variety of conditions. Commonly prescribed opioids include oxycodone, hydrocodone, morphine, and codeine. Other analgesics, such as non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen, are also used to treat pain. Companies in the opioids market include Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.